Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Sells $2,796,292.80 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Fred Burke sold 138,705 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $2,796,292.80. Following the completion of the transaction, the insider now directly owns 413,019 shares of the company’s stock, valued at $8,326,463.04. This trade represents a 25.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Fred Burke also recently made the following trade(s):

• On Tuesday, May 27th, Fred Burke sold 747,102 shares of Guardian Pharmacy Services stock. The stock was sold at an average price of $20.16, for a total value of $15,061,576.32.

Guardian Pharmacy Services Stock Down 0.4%

Shares of NYSE GRDN opened at $21.37 on Friday. The stock has a fifty day moving average price of $23.14 and a two-hundred day moving average price of $22.00. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analysts’ expectations of $321.21 million. On average, research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on GRDN. Raymond James set a $28.00 price objective on Guardian Pharmacy Services and gave the stock an “outperform” rating in a report on Wednesday, May 14th. Truist Financial reissued a “buy” rating and issued a $28.00 price objective (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several large investors have recently modified their holdings of GRDN. Brown Advisory Inc. bought a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth $32,294,000. Geode Capital Management LLC bought a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth $4,073,000. Renaissance Technologies LLC bought a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth $2,859,000. Royce & Associates LP boosted its stake in shares of Guardian Pharmacy Services by 185.3% during the 4th quarter. Royce & Associates LP now owns 214,000 shares of the company’s stock worth $4,336,000 after acquiring an additional 139,000 shares in the last quarter. Finally, Northern Trust Corp bought a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth $1,479,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.